Adar1 Capital Management, LLC Exact Sciences Corp Transaction History
Adar1 Capital Management, LLC
- $500 Billion
- Q4 2024
A detailed history of Adar1 Capital Management, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 5,000 shares of EXAS stock, worth $235,300. This represents 0.06% of its overall portfolio holdings.
Number of Shares
5,000
Previous 15,200
67.11%
Holding current value
$235,300
Previous $1.04 Billion
72.87%
% of portfolio
0.06%
Previous 0.17%
Shares
4 transactions
Others Institutions Holding EXAS
# of Institutions
672Shares Held
164MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$825 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$801 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$568 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.1MShares$567 Million0.13% of portfolio
-
State Street Corp Boston, MA6.23MShares$293 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.33B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...